SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.139+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: waitwatchwander who wrote (885)2/20/2025 11:52:34 AM
From: jargonweary5 Recommendations

Recommended By
Fitzhughlaw
Huggenberg
rodneyh07
TripleE3
urslor

   of 1229
 
True, not yet money in the door but markets — imperfect though they are at times — are anticipatory engines and what they are anticipating (today) is something not good for the share price. My hope and my bet is that the broader market will be proven wrong about IBRX. Happily, that was the case with IMMU, although it took an excruciatingly long time for that to pan out. Since I have grown old investing in these wretched small biotechs my sincere hope is that the market will be proven wrong about IBRX in a much shorter time frame. We will see…assuming I live long enough.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News